Ana M Lorenzo-Mora, Ana M López-Sobaler, Laura M Bermejo, Liliana G González-Rodríguez, Esther Cuadrado-Soto, África Peral-Suárez, María Dolores Salas-González, María Luisa Delgado-Losada, Inmaculada C Rodríguez-Rojo, Ana Barabash, Fernando Maestú-Unturbe, Aránzazu Aparicio
Journal: Nutrients 2023;15(21):4505
PMID: 37960158
BACKGROUND
Mineral intake may protect against cognitive impairment (CI) and all-cause dementia, which affects a large number of adults worldwide. The aim of this study was to investigate the association between mineral intake and Montreal Cognitive Assessment (MoCA), which is a sensitive and specific test.
METHODS
In total, 201 adults were included in a cross-sectional study. They completed a three-day dietary record to estimate their average daily intake of minerals. Contributions to dietary reference intakes (DRIs) were also calculated. The participants were divided into tertiles according to their mineral intake. CI classifications were determined via the MoCA (score < 26). Apolipoprotein E (APOE) genotyping was carried out, and the patients' anthropometric measurements and physical activity, health and personal data were collected.
RESULTS
The prevalence of CI in this selective sample was 54.2% (34.3% females and 19.9% males). In women, being in the third tertiles of iron and manganese intake was associated with lower odds of having CI (OR [95% CI]: 0.32 [0.11 ± 0.93]; 0.33 [0.12 ± 0.93], < 0.05). No significant differences were observed for any of the nutrients studied in men.
CONCLUSIONS
These findings suggest that a low mineral intake, especially low iron and manganese intake in women, is associated with a worse cognition as assessed by MoCA.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.